154 related articles for article (PubMed ID: 8220094)
1. Lung cancer, race, and a CYP1A1 genetic polymorphism.
Shields PG; Caporaso NE; Falk RT; Sugimura H; Trivers GE; Trump BF; Hoover RN; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):481-5. PubMed ID: 8220094
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer risk and CYP1A1 genotype in African Americans.
Taioli E; Ford J; Trachman J; Li Y; Demopoulos R; Garte S
Carcinogenesis; 1998 May; 19(5):813-7. PubMed ID: 9635868
[TBL] [Abstract][Full Text] [Related]
5. Allelic frequency of a p53 polymorphism in human lung cancer.
Weston A; Perrin LS; Forrester K; Hoover RN; Trump BF; Harris CC; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):481-3. PubMed ID: 1302561
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1*2 and CYP1A1*3 polymorphisms cosegregate in the Indian population.
Kotekar A; Bhisey R
Anthropol Anz; 2002 Sep; 60(3):255-60. PubMed ID: 12378791
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Leathart JB; Navidi WC; Carpenter CC; Idle JR
Carcinogenesis; 1997 Jun; 18(6):1203-14. PubMed ID: 9214604
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Cooper J; Navidi WC; Carpenter CL; Idle JR
J Natl Cancer Inst; 1995 Aug; 87(16):1246-53. PubMed ID: 7563171
[TBL] [Abstract][Full Text] [Related]
9. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans.
Kelsey KT; Wiencke JK; Spitz MR
Carcinogenesis; 1994 Jun; 15(6):1121-4. PubMed ID: 8020143
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
12. A novel CYP1A1 gene polymorphism in African-Americans.
Crofts F; Cosma GN; Currie D; Taioli E; Toniolo P; Garte SJ
Carcinogenesis; 1993 Sep; 14(9):1729-31. PubMed ID: 8104732
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Leathart JB; Navidi WC; Idle JR
Pharmacogenetics; 1996 Dec; 6(6):527-33. PubMed ID: 9014202
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
Hung RJ; Boffetta P; Brockmöller J; Butkiewicz D; Cascorbi I; Clapper ML; Garte S; Haugen A; Hirvonen A; Anttila S; Kalina I; Le Marchand L; London SJ; Rannug A; Romkes M; Salagovic J; Schoket B; Gaspari L; Taioli E
Carcinogenesis; 2003 May; 24(5):875-82. PubMed ID: 12771031
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.
Ishibe N; Wiencke JK; Zuo ZF; McMillan A; Spitz M; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1075-80. PubMed ID: 9419406
[TBL] [Abstract][Full Text] [Related]
16. Radical differences in CYP1A1 genotype and function.
Taioli E; Crofts F; Trachman J; Bayo S; Toniolo P; Garte SJ
Toxicol Lett; 1995 May; 77(1-3):357-62. PubMed ID: 7618162
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
18. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population.
Kihara M; Kihara M; Noda K
Carcinogenesis; 1995 Oct; 16(10):2331-6. PubMed ID: 7586131
[TBL] [Abstract][Full Text] [Related]
19. The role of CYP1A1 Msp1 gene polymorphisms on lung cancer development in Turkey.
Demir A; Altin S; Demir I; Köksal V; Cetinçelik U; Dinçer I
Tuberk Toraks; 2005; 53(1):5-9. PubMed ID: 15765281
[TBL] [Abstract][Full Text] [Related]
20. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
